Suppr超能文献

金属蛋白酶及其抑制剂与儿科肺动脉高压的肺动脉僵硬度和心室功能有关。

Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.

机构信息

Division of Cardiology, Heart Institute, Children's Hospital Colorado, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.

Linda Crnic Institute for Down Syndrome, University of Colorado Denver, Aurora, Colorado.

出版信息

Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H242-H252. doi: 10.1152/ajpheart.00750.2020. Epub 2021 Jun 4.

Abstract

Disturbed balance between matrix metalloproteinases (MMPs) and their respective tissue inhibitors (TIMPs) is a well-recognized pathophysiological component of pulmonary arterial hypertension (PAH). Both classes of proteinases have been associated with clinical outcomes as well as with specific pathological features of ventricular dysfunction and pulmonary arterial remodeling. The purpose of this study was to evaluate the circulating levels of MMPs and TIMPs in children with PAH undergoing the same-day cardiac magnetic resonance imaging (MRI) and right heart catheterization. Children with PAH ( = 21) underwent a same-day catheterization, comprehensive cardiac MRI evaluation, and blood sample collection for proteomic analysis. Correlative analysis was performed between protein levels and ) standard PAH indices from catheterization, ) cardiac MRI hemodynamics, and ) pulmonary arterial stiffness. MMP-8 was significantly associated with the right ventricular end-diastolic volume ( = 0.45, = 0.04). MMP-9 levels were significantly associated with stroke volume ( = -0.49, = 0.03) and pulmonary vascular resistance ( = 0.49, = 0.03). MMP-9 was further associated with main pulmonary arterial stiffness evaluated by relative area change ( = -0.79, < 0.01).TIMP-2 and TIMP-4 levels were further associated with the right pulmonary artery pulse wave velocity ( = 0.51, = 0.03) and backward compression wave ( = 0.52, = 0.02), respectively. MMPs and TIMPs warrant further clinically prognostic evaluation in conjunction with the conventional cardiac MRI hemodynamic indices. Metalloproteinases have been associated with clinical outcomes in pulmonary hypertension and with specific pathological features of ventricular dysfunction and pulmonary arterial remodeling. In this study, we demonstrated that plasma circulating levels of metalloproteinases and their inhibitors are associated with standard cardiac MRI hemodynamic indices and with the markers of proximal pulmonary arterial stiffness. Particularly, MMP-9 and TIMP-2 were associated with several different markers of pulmonary arterial stiffness. These findings suggest the interplay between the extracellular matrix (ECM) remodeling and overall hemodynamic status in children with PAH might be assessed using the peripheral circulating MMP and TIMP levels.

摘要

基质金属蛋白酶(MMPs)与其相应组织抑制剂(TIMPs)之间的平衡失调是肺动脉高压(PAH)的一种公认的病理生理组成部分。这两类蛋白酶都与临床结果以及心室功能障碍和肺动脉重塑的特定病理特征相关。本研究旨在评估同一天行心脏磁共振成像(MRI)和右心导管检查的 PAH 患儿的循环 MMP 和 TIMP 水平。PAH 患儿(n=21)行同一天导管检查、全面心脏 MRI 评估和血液样本采集进行蛋白质组学分析。对蛋白水平与)导管检查的标准 PAH 指标、)心脏 MRI 血液动力学和)肺动脉僵硬度进行相关分析。MMP-8 与右心室舒张末期容积显著相关(r=0.45,P=0.04)。MMP-9 水平与每搏量显著相关(r=-0.49,P=0.03)和肺血管阻力(r=0.49,P=0.03)。MMP-9 还与通过相对面积变化评估的主肺动脉僵硬度进一步相关(r=-0.79,P<0.01)。TIMP-2 和 TIMP-4 水平还与右肺动脉脉搏波速度(r=0.51,P=0.03)和后向压缩波(r=0.52,P=0.02)进一步相关。MMPs 和 TIMPs 与常规心脏 MRI 血液动力学指标结合,需要进一步进行临床预后评估。金属蛋白酶与肺动脉高压的临床结果以及心室功能障碍和肺动脉重塑的特定病理特征相关。在这项研究中,我们证明了血浆中循环 MMP 和其抑制剂的水平与标准心脏 MRI 血液动力学指标以及近端肺动脉僵硬度的标志物相关。特别是,MMP-9 和 TIMP-2 与肺动脉僵硬度的多个不同标志物相关。这些发现表明,在 PAH 患儿中,细胞外基质(ECM)重塑与整体血液动力学状态之间的相互作用可以通过外周循环 MMP 和 TIMP 水平来评估。

相似文献

1
Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H242-H252. doi: 10.1152/ajpheart.00750.2020. Epub 2021 Jun 4.
2
Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension.
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H968-H977. doi: 10.1152/ajpheart.00227.2018. Epub 2018 Jul 13.
3
Apparent Aortic Stiffness in Children With Pulmonary Arterial Hypertension: Existence of Vascular Interdependency?
Circ Cardiovasc Imaging. 2017 Feb;10(2). doi: 10.1161/CIRCIMAGING.116.005817.
6
Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension.
Int J Cardiol. 2016 Nov 15;223:821-826. doi: 10.1016/j.ijcard.2016.08.240. Epub 2016 Aug 13.
7
Differences in pulmonary arterial flow hemodynamics between children and adults with pulmonary arterial hypertension as assessed by 4D-flow CMR studies.
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1091-H1104. doi: 10.1152/ajpheart.00802.2018. Epub 2019 Mar 1.
8
Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):209-217. doi: 10.1093/ehjci/jey069.
10

引用本文的文献

4
The TIMP protein family: diverse roles in pathophysiology.
Am J Physiol Cell Physiol. 2024 Mar 1;326(3):C917-C934. doi: 10.1152/ajpcell.00699.2023. Epub 2024 Jan 29.
5
Phenomic Imaging.
Phenomics. 2023 Nov 3;3(6):597-612. doi: 10.1007/s43657-023-00128-8. eCollection 2023 Dec.
7
Pulmonary Vascular Remodeling in Pulmonary Hypertension.
J Pers Med. 2023 Feb 19;13(2):366. doi: 10.3390/jpm13020366.
8
Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening.
Front Immunol. 2022 Oct 5;13:959209. doi: 10.3389/fimmu.2022.959209. eCollection 2022.
9
The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.
BMC Cardiovasc Disord. 2021 Dec 20;21(1):607. doi: 10.1186/s12872-021-02424-5.
10
Matrix Metalloproteinase-8 in Pulmonary Hypertension: The Sheep in the Wolf's Skin?
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1361-1363. doi: 10.1164/rccm.202109-2144ED.

本文引用的文献

2
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Pulm Circ. 2019 Dec 27;9(4):2045894019895414. doi: 10.1177/2045894019895414. eCollection 2019 Oct-Dec.
3
Novel measures of left ventricular electromechanical discoordination predict clinical outcomes in children with pulmonary arterial hypertension.
Am J Physiol Heart Circ Physiol. 2020 Feb 1;318(2):H401-H412. doi: 10.1152/ajpheart.00355.2019. Epub 2019 Dec 20.
4
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2020 Feb 15;201(4):458-468. doi: 10.1164/rccm.201909-1771OC.
5
6
Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension.
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H968-H977. doi: 10.1152/ajpheart.00227.2018. Epub 2018 Jul 13.
7
Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):209-217. doi: 10.1093/ehjci/jey069.
8
Effect of electrical dyssynchrony on left and right ventricular mechanics in children with pulmonary arterial hypertension.
J Heart Lung Transplant. 2018 Jul;37(7):870-878. doi: 10.1016/j.healun.2018.01.1308. Epub 2018 Feb 6.
10
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.
Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验